1. Introduction {#sec1}
===============

The major function of adipose tissue is the storage of fatty acids as an energetic buffer during times of food scarcity. This is accomplished by white adipocytes that store triglyceride in large, unilocular lipid droplets throughout the body. Alternatively, brown adipocytes are tasked with maintaining body temperature by consuming fatty acids via nonshivering thermogenesis under cold environmental temperatures. Although white adipocytes contain few mitochondria, brown adipocytes are packed with mitochondria and generate heat by chemical energy fueled by increasing their cellular metabolic rate. These cells are important during the postnatal period and in times of acute cold stimulation to maintain body temperature. Cold stimulation or pharmacologic activation of adrenergic receptors on brown adipocytes dramatically increases mitochondrial respiration via the uncoupling of the mitochondrial electrochemical gradient via Uncoupling Protein 1 (UCP1). Fatty acid oxidation is critical for this process as it provides the mitochondrial bioenergetics as well as the biophysical activator of uncoupling [@bib1], [@bib2], [@bib3], [@bib4]. Fatty acids are uniquely required for UCP1-induced uncoupling. While cold induces glucose uptake into brown adipocytes and the full oxidation of glucose generates reducing equivalents, brown adipose tissue (BAT) thermogenesis and glucose uptake can be experimentally uncoupled [@bib5], [@bib6]. Consequently, mice with an adipose-specific deficit in fatty acid oxidation are severely cold intolerant, demonstrating an autonomous requirement for adipose fatty acid oxidation in cold-induced thermogenesis [@bib7], [@bib8].

Previously, we generated mice with an adipose-specific defect in fatty acid oxidation by deleting Carnitine Palmitoyltransferase 2 (Cpt2), an obligate step in mitochondrial long chain fatty acid β-oxidation, specifically in adipocytes (Cpt2^A−/−^) [@bib7]. These mice are severely cold intolerant as expected, but did not exhibit an obesogenic phenotype following low or high fat feeding. Similarly, Ucp1KO mice are resistant, rather than prone, to diet-induced obesity under standard housing conditions [@bib9], [@bib10]. Housing Ucp1KO mice at thermoneutrality (30 °C) acutely increases their adiposity, even though thermoneutrality suppresses Ucp1 in white and brown adipose tissue [@bib11]. However, Cpt2^A−/−^ mice did not show increased body weight gain or adiposity at thermoneutrality even though interscapular BAT was lost following housing at 30 °C [@bib12]. This suggests adipose bioenergetics alone is not required for the homeostatic regulation of body weight.

The expression of genes required for thermogenesis are increased with cold and adrenergic stimulation and suppressed through thermoneutral housing. This thermogenic programing and plasticity is an important component of long-term cold tolerance. Although fatty acid oxidation is required for thermogenesis, we were surprised that Cpt2^A−/−^ mice could not induce the expression of thermogenic genes such as *Ucp1*. Acute cold exposure (21 °C--4 °C) or the β3-adrenergic agonist, CL-316243, failed to induce *Ucp1*, *Pgc1α*, and *Dio2* among others in Cpt2^A−/−^ BAT [@bib7]. This deficiency in transcriptional programing was further exacerbated by acclimatizing mice at 30 °C [@bib12]. Therefore, Cpt2^A−/−^ mice represent a unique model to dissect the physiological functions of brown adipocytes *in vivo* because they exhibit molecular, cellular, and biochemical defects that prevented canonical BAT or beige cell function.

To understand the role of fatty acid oxidation to adipose tissue structure, function, and physiology, we subjected Cpt2^A−/−^ mice to disparate thermogenic stimuli including a β3-adrenergic agonist (CL-316243), a thyroid hormone agonist (GC-1) and altered ambient temperature. Here we show that pharmacologic thermogenic agonists induced a loss of UCP1 and BAT morphology in Cpt2^A−/−^ mice, and failed to induce UCP1 and thermogenic programing in white adipose tissue (WAT). However, chronic cold stimulation induced UCP1 and thermogenic programming albeit to a lesser extent in Cpt2^A−/−^ adipose. Structural analysis of Cpt2^A−/−^ BAT revealed increased macrophage infiltration, inflammation, and fibrosis. Finally, obese Cpt2^A−/−^ mice housed at thermoneutrality exhibited a loss in interscapular BAT and were refractory to β-adrenergic-induced energy expenditure and weight loss. These data show that fatty acid oxidation is critical for the maintenance of the brown adipocyte phenotype, particularly under conditions of metabolic stress.

2. Experimental procedures {#sec2}
==========================

2.1. Animals and diets {#sec2.1}
----------------------

Cpt2^A−/−^ and Cpt2^lox/lox^ littermate control mice were generated as previously described [@bib7], [@bib12]. For temperature acclimation studies, 12-week old male and female Cpt2^A−/−^ and Cpt2^lox/lox^ mice were housed in an animal incubator (Key Scientific) at the indicated temperatures for 10 days on a 12 h light/12 h dark cycle and fed a standard chow diet (Teklad Global Rodent Diets). For studies using GC-1 (Tocris; 4554) and CL-316243 (Tocris; 1499), 12-week old male and female Cpt2^A−/−^ and Cpt2^lox/lox^ mice were housed in a facility with ventilated racks on a 12 h light/12 h dark cycle with access to a standard chow diet (Teklad Global Rodent Diets) and were subjected to an intraperitoneal injection with vehicle (0.9% NaCl), CL-316243 (1 mg/kg), or GC-1 (0.3 mg/kg) for 10 consecutive days. Tissue depots for both respective studies were collected on day 11, and were either snap frozen in liquid nitrogen, or stored in Formalin (Sigma) for H&E staining (AML Laboratories).

For the diet study, male Cpt2^A−/−^ and Cpt2^lox/lox^ mice were housed at room temperature on a 12 h light/12 h dark cycle and fed a 60% high-fat diet (Research Diets; D12492) starting at 6-weeks of age (12 weeks on diet). At 12-weeks of age, mice were transferred to an animal incubator at 30 °C on a 12 h light/12 h dark cycle. At 17-weeks of age, the same mice were subjected to an intraperitoneal injection with CL-316243 (1 mg/kg) for 10 consecutive days. Body weights were measured on a weekly basis and on a daily basis during injections with CL-316243. At approximately 18-weeks of age, following the last injection with CL-316243 on day 10, the same mice were individually housed in Comprehensive Laboratory Animal Monitoring System (Columbus Instruments) cages on a 12 h light/12 h dark cycle. O~2~ and CO~2~ consumption and production, respectively, food, and water intake, and home--cage activity were measured continuously. Data were collected for 96 h for ad libitum and a 24 h fasting period. At the end of the study, the same mice were injected with CL-316243 (10 mg/kg) and were monitored for 3 h. Body fat and lean mass of the same mice was measured via magnetic resonance imaging analysis (Minispec MQ10). BAT, iWAT, and gWAT depots were collected for H&E staining.

For the CL-316243 time course experiments, 12-week old male and female Cpt2^A−/−^ and Cpt2^lox/lox^ mice were housed at room temperature on a 12 h light/12 h dark cycle with access to a standard chow diet (Teklad Global Rodent Diets) and subjected to an intraperitoneal injection with CL-316243 (1 mg/kg) at the indicated time points. BAT depots were collected 24 h following the last injection with CL-316243 (days 3, 5, 7, 9, or 11). All procedures were performed in accordance with the NIH\'s *Guide for the Care and Use of Laboratory Animals* and under the approval of the Johns Hopkins Medical School Animal Care and Use Committee.

2.2. Analysis of gene expression by quantitative PCR  {#sec2.2}
-----------------------------------------------------

Total RNA was isolated using Trizol followed by the RNeasy Mini Kit (QIAGEN). RNA was reverse transcribed using the High Capacity cDNA Reverse Transcription Kit (Applied Biosciences). 1--2 ug of cDNA was diluted to 2 ng/ml and was amplified by specific primers in a 20 μl reaction using SsoAdvanced SYBR Green Supermix (Bio-Rad). Analysis of gene expression was carried out in a CFX Connect Real-Time System (Bio-Rad). For each gene, mRNA expression was calculated as 2ˆdeltaCT relative to Rpl22 and 18s expression [@bib13]. Primers and gene information are provided in [Table S1](#appsec1){ref-type="sec"}.

2.3. Western blot {#sec2.3}
-----------------

BAT, iWAT, and gWAT depots were homogenized with 300--500 ul of RIPA buffer (50 mM Tris--HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.25% deoxycholate) containing protease inhibitor cocktail (Roche) and phospho-STOP cocktail (Roche), followed by pelleting of the insoluble debris at 13,000×*g* for 15 min at 4 °C. The protein concentrations of lysates were determined by BCA assay (Thermo Scientific), and 30 μg of lysate was separated by Tris-glycine SDS-PAGE (10% polyacrylamide). Proteins were transferred to nitrocellulose membranes (Protran BA 83, Whatman), blocked in 3% BSA in 1X TBST (Tris-buffered saline with Tween 20), and incubated with primary antibodies overnight. The blots were probed with the following antibodies: Ucp1 (Sigma; U6382), Ndufb8, Sdhb, Uqcrc2, Atp5a (MitoProfile total OXPHOS, Abcam; ab110413), Aco2 (Cell Signaling; 6922), Mcad (GeneTex; GTX32421), Pcx (Abcam; ab128952), Vdac (Calbiochem; PC548), Pdh E2/E3bp (Abcam; ab110333), Acot2 (Sigma; SAB2100030), beta-Actin (Sigma; A2228), and Hsc-70 (Santa Cruz; sc-7298). Cy3-conjugated anti-mouse (Invitrogen), or HRP-conjugated anti-mouse (GE Healthcare) or anti-rabbit (GE Healthcare) secondary antibodies were used appropriately. Images were collected and analyzed using an Alpha Innotech FluorChemQ.

2.4. Transmission electron microscopy {#sec2.4}
-------------------------------------

Samples for TEM were collected and processed as described with minor modifications [@bib14]. BAT was collected and immersed in 3% glutaraldehyde PBS solution and cut into ∼0.5 mM sections with a Mcilwain tissue chopper. The tissue was then fixed in 3% glutaraldehyde, 1% tannic acid, 0.1 M cacodylic acid, 3 mM MgCl2 (pH 7.2, 615 mOsmol). They were then washed with 0.1 M cacodylic acid, 3.5% sucrose, 3 mM MgCl2 (pH 7.2, 331 mOsmol). Then they were postfixed in 0.1 M cacodylic acid, 3 mM MgCl2, 2% OsO4 solution for 2 h. The tissue was then processed for embedding, sectioned and imaged on a Hitachi 7600 transmission electron microscope as we have previously reported [@bib15].

2.5. Statistical analyses {#sec2.5}
-------------------------

Pairwise comparisons were calculated using a two-tailed Student\'s t-test. Two-way ANOVA was utilized for repeated measures such as weight gain over time. Significance was determined as \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001.

3. Results {#sec3}
==========

3.1. β3-adrenergic and thyroid agonists suppress BAT UCP-1 and the browning of iWAT in Cpt2^A−/−^ mice {#sec3.1}
------------------------------------------------------------------------------------------------------

Previously, we generated mice with a loss of long chain fatty acid β-oxidation in adipose tissue by crossing Cpt2 floxed mice with AdipoQ-Cre transgenic mice (herein Cpt2^A−/−^). Fatty acid β-oxidation in adipose tissue was not only critical for thermogenesis as expected but also for the expression of thermogenic genes by acute cold or β3-adrenergic stimulation [@bib7], [@bib12]. Furthermore, acclimatization at thermoneutrality greatly exacerbated this defect whereby acute β3-adrenergic stimulation failed to elicit the stimulation of *Ucp1* expression in Cpt2^A−/−^ BAT [@bib12]. Here, we examined the effect of a chronic low dose of two independent pharmacologic browning agents on BAT, iWAT and gWAT. This was accomplished by administering 10 days of vehicle, a β3-adrenergic agonist CL-316243 (1 mg/kg/day), or a thyroid hormone agonist GC-1 (0.3 mg/kg) to both Cpt2^A−/−^ mice and Cpt2^lox/lox^ littermate controls [@bib16], [@bib17]. Tissue was then collected 24 h following the final injection for examination of histologic, molecular and biochemical thermogenic indicators.

Under all conditions, the BAT of Cpt2^A−/−^ mice contained larger lipid droplets as we have previously observed. Following GC-1 treatment, the increase in lipid droplet size was further exacerbated. Following CL-316243 treatment, the BAT was largely eliminated with mainly large unilocular adipocytes remaining ([Figure 1](#fig1){ref-type="fig"}A). Next, we examined the transcriptional response to chronic stimulation. *Ucp1* and *Cidea* mRNA was suppressed in Cpt2^A−/−^ BAT ([Figure 1](#fig1){ref-type="fig"}B). *Pgc1α* was increased under vehicle conditions but this difference was eliminated by both agonists. *Prdm16* and *Pparα* mRNA was suppressed in CL-316243 and GC-1 treated Cpt2^A−/−^ mice ([Figure 1](#fig1){ref-type="fig"}B). Finally, UCP1 protein was assessed by western blot. Surprisingly, both CL-316243 and GC-1 greatly suppressed UCP1 (∼3fold) in in Cpt2^A−/−^ BAT ([Figure 1](#fig1){ref-type="fig"}C). These data show that two independent pharmacologic browning agents result in not only refractory thermogenic programing in BAT but the suppression of BAT morphology and loss of UCP1 expression.Figure 1**Effect of CL-316243 and GC-1 on adipose tissue of Cpt2**^**A−/−**^**mice**. A) H&E staining of BAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice injected with Saline, 0.3 mg/kg GC-1, or 1 mg/kg CL-316243 for 10 days. Scale bar, 200 um. B) mRNA expression in BAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice injected with Saline, 0.3 mg/kg GC-1, or 1 mg/kg CL-316243 for 10 days (n = 6). C) UCP1 protein expression in BAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice injected with Saline, 0.3 mg/kg GC-1, or 1 mg/kg CL-316243 for 10 days. D) H&E staining of iWAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice injected with Saline, 0.3 mg/kg GC-1, or 1 mg/kg CL-316243 for 10 days. Scale bar, 200 um. E) mRNA expression in iWAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice injected with Saline, 0.3 mg/kg GC-1, or 1 mg/kg CL-316243 for 10 days (n = 6). F) UCP1 protein expression in iWAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice injected with Saline, 0.3 mg/kg GC-1, or 1 mg/kg CL-316243 for 10 days. Arrow indicates Ucp1 band. G) H&E staining of gWAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice injected with Saline, 0.3 mg/kg GC-1, or 1 mg/kg CL-316243 for 10 days. Scale bar, 200 μm H) mRNA expression in gWAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice injected with Saline, 0.3 mg/kg GC-1, or 1 mg/kg CL-316243 for 10 days (n = 6). I) UCP1 protein expression in gWAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice injected with Saline, 0.3 mg/kg GC-1, or 1 mg/kg CL-316243 for 10 days. Arrow indicates Ucp1 band. Western blot quantification is expressed as fold change +/− SE (n = 3). Data are expressed as mean ± SEM. \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001.

The loss of interscacuplar BAT generally leads to an increase in the browning of WAT. To assess the browning of WAT, iWAT and gWAT were examined. Both CL-316243 and GC-1 generated significant browning of iWAT in control mice based on histology, mRNA and UCP1 protein (\>7 fold) expression. However, CL-316243 and GC-1 had little effect on the browning of Cpt2^A−/−^ iWAT ([Figure 1](#fig1){ref-type="fig"}D--F). There was little to no effect of CL-316243 or GC-1 on the browning of gWAT in either control or Cpt2^A−/−^ mice ([Figure 1](#fig1){ref-type="fig"}G--I). These data show that pharmacologic browning agents induce the loss of classical BAT and also fail to induce the browning in WAT in Cpt2^A−/−^ mice.

3.2. β3-adrenergic and thyroid agonists generate a mitochondrial protein imbalance in Cpt2^A−/−^ BAT {#sec3.2}
----------------------------------------------------------------------------------------------------

The loss of fatty acid oxidation in adipose tissue resulted in the agonist-induced loss of UCP1. To understand the effect of a loss of fatty acid oxidation on mitochondrial proteins in general, we performed western blots for other mitochondrial proteins in BAT, iWAT and gWAT in control and Cpt2^A−/−^ mice. Similar to UCP1, NDUFB8, SDHB UQCRC2, ACO2, and MCAD where suppressed (∼2fold) in the BAT of CL-316243 and GC-1 treated Cpt2^A−/−^ mice ([Figure 2](#fig2){ref-type="fig"}A). Some mitochondrial proteins showed no difference in abundance such as PCX and VDAC ([Figure 2](#fig2){ref-type="fig"}A). These data suggest that browning agonists result in a loss of many but not all mitochondrial proteins in Cpt2^A−/−^ BAT.Figure 2**Effect of CL-316243 and GC-1 on mitochondrial proteins in adipose tissue of Cpt2**^**A−/−**^**mice**. A) Western blots of mitochondrial proteins in BAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice injected with Saline, 0.3 mg/kg GC-1, or 1 mg/kg CL-316243 for 10 days. B) Western blots of mitochondrial proteins in iWAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice injected with Saline, 0.3 mg/kg GC-1, or 1 mg/kg CL-316243 for 10 days. C) Western blots of mitochondrial proteins in gWAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice injected with Saline, 0.3 mg/kg GC-1, or 1 mg/kg CL-316243 for 10 days.

Next, we examined the effect of CL-316243 and GC-1 on iWAT and gWAT mitochondrial proteins. Both browning agonists increased mitochondrial protein abundance in iWAT of control mice. In contrast to UCP1, CL-316243 and GC-1 also induced mitochondrial protein abundance in iWAT of Cpt2^A−/−^ mice but to a lesser extent ([Figure 2](#fig2){ref-type="fig"}B). Although CL-316243 and GC-1 did not increase UCP1 in gWAT, they did increase mitochondrial protein abundance in gWAT. Again, Cpt2^A−/−^ mice also increased mitochondrial protein abundance in gWAT but to a lesser extent ([Figure 2](#fig2){ref-type="fig"}C). These data show that although Cpt2^A−/−^ WAT does not increase UCP1 in response to browning agonists, they do increase mitochondrial protein abundance suggesting an alternative thermogenic program.

3.3. Chronic cold stimulation induces UCP1 in BAT and iWAT in Cpt2^A−/−^ mice {#sec3.3}
-----------------------------------------------------------------------------

CL-316243 and GC-1 are pharmacologic agents aimed to simulate cold stimulation. To understand how a physiologic cold stimulation affects adipose tissue in the absence of fatty acid oxidation, control and Cpt2^A−/−^ mice were housed at 15 °C, 21 °C and 30 °C for 10 days to match the pharmacologic intervention. Although Cpt2^A−/−^ BAT contains more lipid droplet area and less Ucp1 mRNA and UCP1 protein under all temperatures, chronic cold still induces Ucp1 mRNA and UCP1 protein ([Figure 3](#fig3){ref-type="fig"} A**--**C). Consistent with our previous results, housing Cpt2^A−/−^ mice at thermoneutrality eliminates UCP1 and classical interscapular BAT morphology [@bib12]. Also, in contrast to thermogenic agonists, chronic cold elicited the browning of iWAT at the histological, mRNA and protein level in Cpt2^A−/−^ mice ([Figure 3](#fig3){ref-type="fig"}D--F). Again, gWAT showed little evidence of browning and there was no difference between control and Cpt2^A−/−^ mice ([Figure 3](#fig3){ref-type="fig"}G--I). Housing mice at thermoneutrality had little effect on the overall protein abundances of mitochondrial proteins. However, thermoneutrality suppressed mitochondrial protein abundance in Cpt2^A−/−^ BAT, suggesting that thermoneutrality requires fatty acid oxidation to maintain BAT integrity ([Figure 4](#fig4){ref-type="fig"}A). iWAT responded to cold challenge by increasing mitochondrial proteins equally in control and Cpt2^A−/−^ mice ([Figure 4](#fig4){ref-type="fig"}B). gWAT elicited minor effects on mitochondrial protein abundance in both genotypes ([Figure 4](#fig4){ref-type="fig"}C). Finally, we examined the mRNA expression of *Fgf21* in adipose tissue of both cold and agonist-induced control and Cpt2^A−/−^ mice. Fgf21 is highly induced in liver and muscle that are deficient in fatty acid oxidation [@bib18], [@bib19], [@bib20]. Cold exposure increased the expression of *Fgf21* in Cpt2^A−/−^ BAT ([Figure 5](#fig5){ref-type="fig"}A). Adrenergic or thyroid agonists did not further potentiate this response ([Figure 5](#fig5){ref-type="fig"}A). iWAT and gWAT did not show significant changes in Fgf21 expression ([Figure 5](#fig5){ref-type="fig"}B,C). Together, these results show that cold exposure uniquely regulates adipose function compared to β3-adrenergic and thyroid agonist stimulation.Figure 3**Effect of ambient temperature on adipose tissue of Cpt2**^**A−/−**^**mice**. A) H&E staining of BAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice acclimated to 15 °C, 21 °C, or 30 °C for 10 days. Scale bar, 200 um. B) mRNA expression in BAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice acclimated to 15 °C, 21 °C, or 30 °C for 10 days (n = 6). C) UCP1 protein expression in BAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice acclimated to 15 °C, 21 °C, or 30 °C for 10 days. D) H&E staining of iWAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice acclimated to 15 °C, 21 °C, or 30 °C for 10 days. Scale bar, 200 um. E) mRNA expression in iWAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice acclimated to 15 °C, 21 °C, or 30 °C for 10 days (n = 6). F) UCP1 protein expression in iWAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice acclimated to 15 °C, 21 °C, or 30 °C for 10 days. Arrow indicates Ucp1 band. G) H&E staining of gWAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice acclimated to 15 °C, 21 °C, or 30 °C for 10 days. Scale bar, 200 um. H) mRNA expression in gWAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice acclimated to 15 °C, 21 °C, or 30 °C for 10 days (n = 6). I) UCP1 protein expression in gWAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice acclimated to 15 °C, 21 °C, or 30 °C for 10 days. Arrow indicates Ucp1 band. Western blot quantification is expressed as fold change +/− SE (n = 3). Data are expressed as mean ± SEM. \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001.Figure 4**Effect of ambient temperature on mitochondrial proteins in adipose tissue of Cpt2**^**A−/−**^**mice**. A) Western blots of mitochondrial proteins in BAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice acclimated to 15 °C, 21 °C, or 30 °C for 10 days. B) Western blots of mitochondrial proteins in iWAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice acclimated to 15 °C, 21 °C, or 30 °C for 10 days. C) Western blots of mitochondrial proteins in gWAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice acclimated to 15 °C, 21 °C, or 30 °C for 10 days.Figure 5**Loss of fatty acid oxidation induces Fgf21 in BAT**. A) Fgf21 expression in BAT of 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice acclimated to different ambient temperature or thermogenic agonists for 10 days (n = 6). B) Fgf21 expression in iWAT of 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice acclimated to different ambient temperature or thermogenic agonists for 10 days (n = 6). C) Fgf21 expression in gWAT of 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice acclimated to different ambient temperature or thermogenic agonists for 10 days (n = 6). Data are expressed as mean ± SEM. \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001.

3.4. Brown adipose tissue of Cpt2^A−/−^ mice exhibit macrophage infiltration, inflammation and fibrosis {#sec3.4}
-------------------------------------------------------------------------------------------------------

To understand the development of BAT dysfunction in response to browning agonists, control and Cpt2^A−/−^ mice were again treated with CL-316243 (1 mg/kg/day) and BAT was collected over 10 days. Gross and histological examination revealed that after 4 days of CL-316243 treatment, most of the interscapular BAT had become dysmorphic ([Figure 6](#fig6){ref-type="fig"}A). Additionally, UCP1 protein and other mitochondrial proteins were suppressed by day 4 ([Figure 6](#fig6){ref-type="fig"}B,C). Upon closer examination, Cpt2^A−/−^ BAT contained an abundance of infiltrating leukocytes ([Figure 7](#fig7){ref-type="fig"}A). Therefore, we examined BAT for markers of macrophage infiltration and local inflammation. Cpt2^A−/−^ BAT exhibited increased markers for macrophage mRNA such as *F4/80* and *Cd68* irrespective of CL-316243, GC-1 or temperature ([Figure 7](#fig7){ref-type="fig"}B,C). Additionally, Cpt2^A−/−^ BAT expressed higher *Tnfα*, and *Mcp1* as well as other inflammatory markers consistent with higher inflammatory status in the Cpt2^A−/−^ BAT depot ([Figure 7](#fig7){ref-type="fig"}B,C). These data show that Cpt2^A−/−^ BAT (but not WAT [@bib7]) exhibits significant chronic inflammation.Figure 6**Time course of CL-316243 mediated dysfunction in Cpt2**^**A−/−**^**BAT**. A) H&E staining of BAT from Cpt2^A−/−^ and Cpt2^lox/lox^ mice after injection with 1 mg/kg CL-316243 for 0, 2, 4, 6, or 8 days. Scale bar, 200 um. B) Western blots of representative proteins in oxidative phosphorylation complexes I, II, III, and V in BAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice injected with 1 mg/kg CL-316243 for 0, 2, 4, 6, 8, and 10 days. C) Mitochondrial protein expression in BAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice injected with 1 mg/kg CL-316243 for 0, 2, 4, 6, 8, and 10 days.Figure 7**Loss of adipose fatty acid oxidation causes macrophage infiltration and inflammation in BAT**. A) H&E staining of BAT from Cpt2^A−/−^ and Cpt2^lox/lox^ mice after injection with 1 mg/kg CL-316243 for 0, 2, 4, 6, or 8 days. B) mRNA expression of macrophage & inflammatory genes in BAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice injected with Saline, 0.3 mg/kg GC-1, or 1 mg/kg CL-316243 for 10 days (n = 6). C) mRNA expression of macrophage & inflammatory genes in BAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice acclimated to 15 °C, 21 °C, or 30 °C for 10 days (n = 6). Data are expressed as mean ± SEM. \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001.

To examine the subcellular structure of BAT, control and Cpt2^A−/−^ BAT was examined by Transmission Electron Microscopy (TEM). Consistent with the histological and transcriptional data showing increased macrophage infiltration, Cpt2^A−/−^ BAT exhibited an abundance of phagocytic cells. Based on the substantial changes in mitochondrial protein abundance, we were surprised that many mitochondria of Cpt2^A−/−^ BAT exhibited normal morphology with abundant cristae. However, Cpt2^A−/−^ BAT did exhibit evidence of dysmorphic mitochondria ([Figure 8](#fig8){ref-type="fig"} **white arrowheads**) and significant cellular and subcellular heterogeneity. Strikingly, Cpt2^A−/−^ BAT exhibited abundant fibrin deposition ([Figure 8](#fig8){ref-type="fig"} **black arrowheads**). These data show that Cpt2^A−/−^ mice exhibit structurally normal BAT and mitochondria, interspersed with dysmorphic cells and organelles including large fibrotic areas.Figure 8**Transmission Electron Micrographs of control and Cpt2**^**A−/−**^**BAT**. TEM of BAT from 16-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice. Scale bars, 2 um and 500 nm, respectively. White arrowheads pointing to dysmorphic mitochondria. Black arrowheads pointing to fibrin deposition. Lipid Droplet (LD), Red Blood Cell (RBC).

To further examine the fibrin deposition, we assayed genes involved in adipose tissue fibrosis [@bib21]. First, we examined microarray data that we have previously published [@bib12]. This data revealed a large number of genes upregulated in Cpt2^A−/−^ BAT. To validate these results, we performed qPCR analysis of genes identified by microarray analysis. Cpt2^A−/−^ BAT showed significant upregulation of collagen genes including consistent changes in *Col3a1*, *Col5a1* and *Col6a1* ([Figure 9](#fig9){ref-type="fig"}A,B). Additionally, *Decorin*, *Elastin*, and *Lumican* were significantly upregulated under all conditions ([Figure 9](#fig9){ref-type="fig"}A,B). Finally, we identified *Mmp12*, a macrophage specific enzyme that degrades ECM, massively upregulated under all conditions in Cpt2^A−/−^ BAT ([Figure 9](#fig9){ref-type="fig"}C,D). Together these data suggest that the loss of adipose fatty acid oxidation results in increased tissue turnover and inflammation in BAT, and that fatty acid oxidation is important for BAT cellular and tissue maintenance.Figure 9**Loss of adipose fatty acid oxidation induces genes in extracellular matrix**. A) mRNA expression of collagen and extracellular matrix genes in BAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice injected with Saline, 0.3 mg/kg GC-1, or 1 mg/kg CL-316243 for 10 days (n = 6). B) mRNA expression of collagen and extracellular matrix genes in BAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice acclimated to 15 °C, 21 °C, or 30 °C for 10 days (n = 6). C) Mmp-12 mRNA expression in BAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice injected with Saline, 0.3 mg/kg GC-1, or 1 mg/kg CL-316243 for 10 days (n = 6). D) Mmp-12 mRNA expression in BAT from 12-week old Cpt2^A−/−^ and Cpt2^lox/lox^ mice acclimated to 15 °C, 21 °C, or 30 °C for 10 days (n = 6). Data are expressed as mean ± SEM. \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001.

3.5. Adipose fatty acid oxidation is required for acute β3-adrenergic-induced weight loss {#sec3.5}
-----------------------------------------------------------------------------------------

Previously we showed that Cpt2^A−/−^ mice were not more prone to weight gain on high or low fat diets, and in contrast to Ucp1KO mice, were not prone to weight gain at thermoneutrality even though the adipose tissue was bioenergetically and transcriptionally incompetent for thermogenesis [@bib7], [@bib12]. Additionally, both housing at thermoneutrality and 10 days of CL-316243 eliminate BAT in Cpt2^A−/−^ mice. Here we used Cpt2^A−/−^ mice to understand the physiologic role of BAT on body weight gain. First, control and Cpt2^A−/−^ mice were placed on a high fat diet for 6 weeks to induce an obese phenotype. Then they were placed at thermoneutrality and remained on the HFD for an additional 5 weeks to eliminate BAT from Cpt2^A−/−^ mice. Under this paradigm, there was, again, no genotypic difference in body weight of the mice ([Figure 10](#fig10){ref-type="fig"}A). The mice were then given 10 days of CL-316243 (1 mg/kg/day). CL-316243 induced rapid weight loss in control mice, but Cpt2^A−/−^ mice were resistant to CL-316243 induced weight loss ([Figure 10](#fig10){ref-type="fig"}B). As expected, upon gross examination, Cpt2^A−/−^ mice did not exhibit an appreciable interscapular BAT depot ([Figure 10](#fig10){ref-type="fig"}C). Histological examination confirmed a significant loss of BAT without concomitant browning of iWAT or gWAT in Cpt2^A−/−^ mice ([Figure 10](#fig10){ref-type="fig"}D). Examination of energy expenditure and RER by indirect calorimetry did not reveal differences during ad libitum feeding ([Figure 10](#fig10){ref-type="fig"}E). However, Cpt2^A−/−^ mice better maintained energy expenditure during a 24hr fast ([Figure 10](#fig10){ref-type="fig"}F). Administration of CL-316243 revealed a robust increase in energy expenditure in control mice, but Cpt2^A−/−^ mice were refractory to CL-316243 administration as expected ([Figure 10](#fig10){ref-type="fig"}G). Interestingly, control and Cpt2^A−/−^ mice both exhibited decreased RER upon CL-316243, suggesting that although CL-316243 induced lipolysis equally well in both animals, acute changes in energy expenditure require adipose fatty acid oxidation.Figure 10**Adipose fatty acid oxidation is required for acute β3-adrenergic-induced weight loss**. A) Body weights male Cpt2^A−/−^ and Cpt2^lox/lox^ littermate control mice on HFD for 6-weeks at 22 °C and 6 weeks at 30 °C. Arrows indicate the start of high-fat diet feeding and injections with 1 mg/kg CL-316243 (n = 10--14). B) Loss in body weight of male Cpt2^A−/−^ and Cpt2^lox/lox^ littermate control mice after injections with 1 mg/kg CL-316243 for 10 days at 30 °C (n = 10--14). C) Gross interscapular BAT morphology of male Cpt2^A−/−^ and Cpt2^lox/lox^ littermate control mice housed at 30 °C on high-fat diet plus 1 mg/kg CL-316243 injections for 10 days. D) H&E staining of BAT, iWAT, and gWAT from male Cpt2^A−/−^ and Cpt2^lox/lox^ littermate control mice housed at 30 °C on high-fat diet plus 1 mg/kg CL-316243 injections for 10 days. Scale bar, 200 um. E) VO~2~ consumption and RER of male Cpt2^A−/−^ and Cpt2^lox/lox^ littermate control mice housed at 30 °C on high-fat diet plus 1 mg/kg CL-316243 injections for 10 days (n = 9--14). Data were collected during a 96 h ad libitum period, 24 h fast, 24 h reefed, and 3 h after injection with 10 mg/kg CL-316243. F) Energy expenditure of male Cpt2^A−/−^ and Cpt2^lox/lox^ littermate control mice housed at 30 °C on high-fat diet plus 1 mg/kg CL-316243 injections for 10 days under fed, fast, and re-fed conditions (n = 9--14). G) VO~2~ consumption of male Cpt2^A−/−^ and Cpt2^lox/lox^ littermate control mice housed at 30 °C on high-fat diet plus 1 mg/kg CL-316243 injections for 10 days. VO~2~ consumption was measured for 3 h after injection with 10 mg/kg CL-316243 (n = 9--14). Data are expressed as mean ± SEM. \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001.

4. Discussion {#sec4}
=============

There has been great interest in the development of new therapies to combat human obesity. Many have suggested that recruiting and harnessing brown adipose tissue to dissipate as opposed to store fatty acids would represent a viable anti-obesity therapy [@bib22], [@bib23]. Indeed, the activation of thermogenesis by the administration of adrenergic ligands or thyroid agonists has been shown to reduce adiposity in rodents [@bib16], [@bib17]. Chemical uncoupling agents are effective weight loss agents in humans although dangerous as originally administered [@bib24], [@bib25]. Second generation tissue specific uncouplers may circumvent this toxicity [@bib26], [@bib27]. However, from a mechanistic standpoint, it is not clear what the adipose-specific roles of increasing energy expenditure are in combating obesity. That is, are the actions of these weight loss agents due to an increase in adipose bioenergetics or by acting on multiple tissues simultaneously. Even in cases where brown adipose tissue has been specifically targeted and shown to prevent weight gain, it is not clear what the role autonomous bioenergetics plays as opposed to endocrine roles for adipocytes [@bib28]. In order to understand the bioenergetic roles of adipocytes *in vivo* we have inhibited the ability of adipose tissue to oxidize fatty acids, and consequently limited their ability to increase energy expenditure in response to cold or thermogenic agonists.

We have previously shown that acute cold failed to induce *Ucp1* in BAT of Cpt2^A−/−^ mice [@bib7]. Additionally, the β3-adrenergic agonist CL-316243, adrenergic agonist isopreterenol and adenylate cyclase activator forskolin all failed to induce Ucp1 in Cpt2^A−/−^ BAT even though PKA signaling and CREB activation remained intact [@bib7]. To understand the long-term effects of thermogenic activation in mice with defective BAT, we treated control and Cpt2^A−/−^ mice with a low dose of CL-316243 and the thyroid hormone agonist GC-1 for 10 days. Under these conditions, both agonists induced not just a failure to induce *Ucp1* in BAT, but UCP1 was lost in addition to BAT morphology. Therefore, activation of these thermogenic pathways was not merely refractory in Cpt2^A−/−^ mice but was detrimental. The inability to oxidize fatty acids resulted in agonist-induced deformation of BAT. Normally when classical interscapular BAT is lost, there is a concomitant increase in beige adipocytes. Surprisingly, this did not occur in Cpt2^A−/−^ mice as these mice were also refractory to the browning of white adipose tissue. These data demonstrate the requirement of adipose fatty acid oxidation to BAT function and survival following chronic activation by disparate thermogenic agonists.

An examination of Cpt2^A−/−^ BAT histology revealed a significant infiltration of leukocytes. Transcriptional profiling showed that Cpt2^A−/−^ BAT exhibited a significant macrophage infiltration with corresponding inflammatory markers. Macrophage infiltration has been shown to suppress *Ucp1* [@bib29]. Therefore, it is conceivable that the excessive macrophage infiltration into BAT could be partially responsible for the suppression in UCP1 expression in Cpt2^A−/−^ mice although the role of macrophages in cold-induced thermogenesis remains unclear [@bib30]. These results along with the imbalance in mitochondrial protein abundance prompted us to take a closer look at BAT from Cpt2^A−/−^ mice. Therefore, we examined the cellular and intracellular morphology of Cpt2^A−/−^ BAT by TEM. Although, the BAT depot is much smaller in Cpt2^A−/−^ mice, many of the brown adipocytes that remained exhibited surprisingly normal ultrastructure. However, there was more heterogeneity in Cpt2^A−/−^ BAT, which exhibited unhealthy adipocytes and dysmorphic mitochondria. Strikingly, Cpt2^A−/−^ BAT exhibited large patches of intercellular fibrin depositions as well as infiltrating phagocytic cells. These static snapshots likely portend a highly dynamic BAT in Cpt2^A−/−^ mice owning to the importance of fatty acid oxidation for the survival and maintenance of brown adipocytes.

We were surprised to see that chronic cold exposure (15 °C) did not result in a loss of BAT but rather increased *Ucp1* in Cpt2^A−/−^ mice. BAT from Cpt2^A−/−^ mice always expresses a lower amount of *Ucp1* but *Ucp1* is nonetheless regulated by ambient temperature in Cpt2^A−/−^ mice. This is in contrast to the acute (4 °C) cold exposure of Cpt2^A−/−^ mice [@bib7]. Ucp1KO mice are acutely sensitive to 4 °C, but can survive cold exposure if they are first acclimatized to 15 °C [@bib31]. Chronic cold acclimatization likely elicits a unique program from acute cold stimulation (shock) that does not rely on adipose fatty acid oxidation [@bib32]. It may well be simply the difference in kinetics, or the signals elicited by cold acclimatization may be different than cold stimulation. In contrast, Cpt2^A−/−^ mice acclimatized to thermoneutrality (30 °C), lose BAT similar to acute cold stimulation. Therefore, fatty acid oxidation is required both for survival of brown adipocytes under acute stimulated and quiescent states. Interestingly, although chronic cold stimulation somewhat rescues BAT structure in Cpt2^A−/−^ mice, there was not a resolution in macrophage infiltration. Again, we would speculate that BAT turnover is high under all conditions, but recruitment of new brown adipocytes outpaces adipocyte demise during chronic cold stimulation.

Finally, we examined the physiologic significance of adipose fatty acid oxidation and brown/beige cells in general. We essentially eliminated brown adipocytes in Cpt2^A−/−^ mice by maintaining them at thermoneutrality followed by 10 days of CL-316243 administration. This evoked the loss of interscapular BAT while inhibiting the browning of white adipose tissue. While there was again no difference in body weight between control and Cpt2^A−/−^ mice, obese Cpt2^A−/−^ mice were resistant to energy expenditure and weight loss elicited by CL-316243. Therefore, brown adipose tissue is an important component to acute adrenergic-induced weight loss, but long-term physiologic adaptations likely prevent changes in weight over the long-term. Still, it is not clear if this will be an effective weight loss strategy in adult obese humans that have a limited quantity of brown adipose tissue.

Fatty acid oxidation is an important metabolic process in adipose tissue, particularly for brown and beige adipocytes. The loss of adipose fatty acid oxidation results in severe cold intolerance but normal adiposity. We have found that fatty acid oxidation contributes not only to adipose bioenergetics but is also critical for brown adipose tissue survival under acute thermogenic activation and during times of BAT quiescence. These data show that fatty acid oxidation is critical for the maintenance of the brown adipocyte phenotype, particularly under conditions of metabolic stress.
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